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AbstrAct
Objectives Low-income and lower middle-income 
countries (LLMICs) bear a disproportionate burden 
of non-communicable diseases (NCDs). WHO has 
repeatedly called for more research on poverty and 
NCDs in these settings, but the current situation 
remains unquantified. We aimed to assess research 
output on poverty and NCD risk factors from these 
countries in relation to upper middle-income and high-
income countries.
Design Bibliometric analysis of primary research 
published between 1 January 1990 and 4 May 2017. 
We searched 13 databases, combining terms for 
poverty and NCD behavioural risk factors (tobacco, 
alcohol, diet and physical activity). Independent 
dual review was used to screen titles, abstracts and 
full papers. Two-tailed t-testing and multiple linear 
regression analyses were used to compare differences 
in means.
Outcomes (1) Proportion of lead authors affiliated 
with institutions based in high and upper middle-
income countries vs LLMICs. (2) Mean number of 
citations for publications from each region. (3) Mean 
journal impact factor for studies from each region.
results Ninety-one (67%) of the 136 included 
studies were led by scientists affiliated with LLMIC-
based institutions. These authors represented 17/83 
LLMICs (20%), and their studies garnered 4.8 fewer 
citations per paper than studies led by high-income 
and upper middle-income-affiliated authors; however, 
this finding was non-significant (P=0.67). Papers led 
by authors based in high-income and upper middle-
income countries were published in journals with a 
mean impact factor 3.1 points higher than those from 
LLMICs (4.9 vs 1.7) adjusting for year of publication 
and number of citations (P<0.001).
conclusions Most poverty and NCD risk factor 
research is led by authors from a small number of 
LLMICs. These studies are being published in relatively 
low-impact journals, and the vast majority of LLMICs 
are not producing any research in this area that is 
vital to their social and economic development. The 
paucity of domestic evidence must be addressed to 
inform global policy.
bAckgrOunD
Non-communicable diseases (NCDs)—
including cardiovascular diseases, diabetes, 
cancer and respiratory diseases—cause 
around two-thirds of global deaths, of which 
16 million per year are premature (occur-
ring before 70 years of age).1 2 Over 80% of 
NCD mortality occurs in low-income and 
middle-income countries (LMICs), and indi-
viduals in these countries have a 50% higher 
risk of premature death compared with 
individuals living in high-income countries 
(HICs).1 3 NCDs have been described as the 
social justice issue of our generation and as 
one of the greatest development challenges 
of the 21st century.4 5 
The bidirectional relationship between 
income and NCDs is fractal: these conditions 
incur international, national, household and 
individual financial costs through lost produc-
tivity, unemployment and long-term medical 
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Research
strengths and limitations of this study
 ► The WHO Global Action Plan and the WHO Prioritised 
Research Agenda both call for increased non-
communicable disease (NCD) research without 
quantitative justification; this is the first study to 
assess the quantity and quality of NCD and poverty 
research by World Bank region.
 ► We used a comprehensive search strategy, 13 major 
databases and independent dual review to maximise 
our chances of including all relevant papers.
 ► We focused our assessment on research that 
examines the association between poverty and NCD 
risk factors in developing countries; one of the most 
important aspects of the NCD epidemic from a policy 
standpoint.
 ► Research on other aspects of NCDs was not captured 
by our search.
 ► Impact factors and numbers of citations are 
imperfect proxies for quality.
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Figure 1 Income classification of countries in each World 
Bank geographical region.
expenses.6–12 The lost economic output in LMICs from 
2011 to 2015 was estimated at US$7 trillion.12
Poverty exposes individuals to the adverse political, 
economic and cultural conditions that cause NCDs 
and increases the risks of experiencing disability and 
premature death.1 13–22 Common factors include poor 
schooling, inadequate housing, hazardous workplaces 
and unplanned urbanisation.1 Behavioural risk factors 
such as tobacco and alcohol use, poor diet and physical 
inactivity are central in mediating socioeconomic NCD 
inequalities.
The story is not the same in every country, for instance, 
the correlation between physical activity and socioeco-
nomic status is mediated by Gross National Income: 
obesity is a bigger problem for poorer groups in high-in-
come countries but mainly affects affluent groups in 
low-income countries.22 In short, the factors that mediate 
the bidirectional relationship between poverty and NCDs 
are highly context-specific. High-income trends are not 
necessarily generalisable to the world’s poorest countries, 
which often have higher relative and absolute burdens of 
NCDs.
Research on the relationship between poverty and NCD 
risk factors within developing countries is critical for the 
development of evidence-based, context-specific policy 
interventions; especially for addressing NCDs within the 
wider development agenda. The 2015 Sustainable Devel-
opment Goals and the WHO Global Action Plan on NCDs 
both emphasise building national research capacity.23 24 
These recommendations lack quantitative justification as 
we have little evidence about the current state of NCD 
research in the world’s poorest countries. A previous 
bibliometric analysis of WHO ‘Best Buy’ implementation 
in LMICs showed wide variation between regions and the 
risk factors assessed, but no studies have specifically exam-
ined poverty and NCD risk factor research.25
We conducted a bibliometric analysis to fill this gap 
and assess likely impact of poverty and NCD risk factor 
research from low-income and lower middle-income 
countries (LLMICs) versus upper middle-income and 
high-income countries.
MethODs
Our primary objective was to quantify the proportion 
of poverty and NCD behavioural risk factor research 
in LLMICs that is led by LLMIC-affiliated researchers. 
The World Bank lists 83 LLMICs, with the vast majority 
of low-income countries concentrated in Sub-Saharan 
Africa (figure 1).
Secondary outcomes were estimates of research 
impact for publications from each World Bank income 
region derived from impact factor metrics and cumula-
tive citations. We also extracted data on publication year, 
geographical region, study funder and which NCD risk 
factors were assessed.
We developed a search strategy that incorporated 
Medical Subject Headings terms and synonyms for NCDs, 
individual conditions, NCD risk factors, poverty, proxies 
for socioeconomic status and the 2015 World Bank list of 
LLMICs from the 2015 analytical classification.26
We ran the search (reproduced fully in online supple-
mentary appendix 1) on Embase, Medline, Web of Science, 
Global Health and TRoPHI. We also searched grey liter-
ature in digital dissertations (Global full-text plus), 
WHOLIS (WHO Library) and the WHO regional data-
bases: AIM (AFRO), LILACS (AMRO/PAHO), IMEMR 
(EMRO), IMSEAR (SEARO) and WPRIM (WPRO). 
We reviewed the first 100 hits from Google Scholar and 
searched Medline in-process and other non-indexed cita-
tions and the websites of the World Bank, Department 
for International Development, United States Agency 
for International Development and WHO, as well as 
scrutinising reference lists and contacting key authors to 
uncover additional or forthcoming work. We conducted 
the search in English but did not restrict results by 
language or age.
After duplicate removal, titles, abstracts and full-texts 
were independently screened by two reviewers with a 
random 10% sample screened by a third author. We 
included records written in English, Spanish, French, 
Portuguese, Italian and Sinhalese; published from 1 
January 1990 to 4 May 2017; presenting primary data on 
one or more NCD behavioural risk factor stratified by one 
or more measures of poverty; with the study population 
based in one of the 83 World Bank-defined LLMICs.
From the included papers, we calculated the propor-
tion of lead researchers (first authors) affiliated with 
institutions based in each World Bank region. Where 
an author was affiliated with two institutions, they were 
coded according to the higher-income country. We also 
recorded the number of times each article had been cited 
and the impact factor of the journal that the paper was 
published in, using Thompson Reuters data. This allowed 
us to derive a proxy measure for research impact. We used 
STATA (StataCorp) to perform two-tailed t-testing and 
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Figure 2 Preferred reporting items for systematic reviews and meta-analysis flow diagram. LLMIC, low-income and 
lower middle-income country; NCD, non-communicable disease.
Figure 3 Location of lead authors institution and study 
population.
linear regression analysis to determine whether differ-
ences in mean citations and mean journal impact factor 
were significant, using a threshold of P<0.05. Ethical 
approval was not required.
results
At both stages of screening Cohen’s κ for inter-rater 
agreement was >0.75 (considered ‘excellent agreement’). 
Our literature search returned 6749 records, and 106 
additional records were retrieved from other sources. 
After screening, 136 papers met our inclusion criteria 
(see figure 2).
Four studies assessed populations based in more than 
one LLMIC. The remaining 132 showed a strong prepon-
derance for South Asia, with almost half of the studies 
conducted in Indian populations (figure 3). Eighty-four 
of the 136 papers (62%) were funded by LLMIC-based 
agencies.
Ninety-one (67%) of the publications were led by 
authors affiliated with LLMIC-based institutions. These 
authors collectively represented 17 out of 83 World 
Bank-defined LLMICs; Benin, Ethiopia and Nepal 
were the only low-income countries represented by first 
authors. There were no papers from authors affiliated 
with institutions from 80% of all LLMICs.
Forty-five papers (33%) were led by authors affiliated 
with high-income or upper middle-income countries. 
There was no clear trend over time in the proportion 
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Figure 4 Proportion of studies led by authors affiliated with 
each income grouping from 1995 to 2017.
Figure 5 Total number of studies each year and 
first author’s affiliation.
Table 1 Study designs
Study design No of studies
Cross-sectional 102
Case–control 18
Prospective cohort 10
Retrospective cohort 4
RCT 1
Before–after 1
RCT, randomised controlled trial.
of papers led by higher versus lower income-affiliated 
authors (figure 4).
The number of papers published on poverty and NCD 
risk factors every year from 1995 to May 2017 has gener-
ally increased (figure 5). The most common study design 
is cross-sectional (table 1).
Table 2 shows that studies led by LLMIC-affiliated 
authors tended to had a much larger mean population 
size than those led by high-income/upper middle-in-
come authors (380 152 vs 17 025).
The 45 papers led by authors affiliated with high-in-
come/upper middle-income institutions were published 
in journals with a mean impact factor of 4.9 (figure 6). 
This was 3.2 points higher (95% CI 1.6 to 4.9) than papers 
led by LLMIC-affiliated researchers (mean impact factor 
1.7). T-testing showed that the difference in means was 
significant at the 0.05 level (P<0.001).
Controlling for year of publication and number of 
citations, regression analysis showed that papers led by 
high-income and upper middle-income-affiliated authors 
were published in journals with an impact factor 3.1 
points higher than those from LLMIC authors (P<0.001).
LLMIC-based authors garnered an average of 22.0 
citations per paper; 4.8 fewer than the average paper 
from high-income and upper middle-income-affiliated 
authors; however, the difference between the means did 
not reach significance (P=0.67, 95% CI for difference in 
means −13.7 to 21.3).
Most studies (65%) assessed the association between 
poverty and a single risk factor; 21% assessed two risk 
factors; 8% examined three and 6% examined all four. As 
figure 7 demonstrates, tobacco was the most commonly 
assessed. Online supplementary file 1 provides study-level 
data on risk factors, country origins and paper metrics.
Papers assessing tobacco that were led by LLMIC 
authors were published in journals with a mean impact 
factor 4.6 times lower than those from high-income and 
upper middle-income-affiliated authors (P<0.001, 95% CI 
for difference in means 2.1 to 7.0). Differences in mean 
citations were non-significant at the 0.05 level.
DiscussiOn
This study is the first attempt to quantify research output 
on poverty and NCD risk factors in the countries that bear 
the greatest burden of NCD morbidity and mortality.3 
Although LLMIC-affiliated scientists led 67% of the 
included papers, 80% of LLMICs have not produced any 
publications on poverty and NCD behavioural risk factors.
There were only two interventional studies, and the 
remainder were either cross-sectional, case–control or 
cohort studies. The same pattern in risk factor assess-
ment was seen in every region with tobacco and diet 
being assessed more frequently than physical activity and 
alcohol use.
Papers led by authors based in high-income and 
upper middle-income countries were published in jour-
nals with a mean impact factor approximately three times 
higher than papers from LLMICs, after adjusting for cita-
tions and year of publication. We found a non-significant 
difference in mean citations for papers from higher versus 
lower income countries. Our findings do not provide 
evidence as to why LLMIC-based research has a lower 
impact, but we speculate that national research funding, 
the quality of health research training, institutional 
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Table 2 Study characteristics
Lead author’s institutional 
affiliation Low Lower middle Upper middle High
Low and 
lower middle
Upper middle and 
high
No of studies (% total) 5 (4) 86 (63) 1 (1) 44 (32) 91 (66) 45 (33)
Received funding from high/
upper middle
0 14 1 37 14 38
Mean publication year 2005 2010 2013 2011 2009 2011
Mean citations 47.6 21.5 18.0 27.0 22.0 26.8
Mean impact factor 1.1 1.7 3.2 5.0 1.7 4.9
Mean population size 627 403 879 2983 173 376 380 152 17 025
Figure 6 Lead author’s location and paper metrics.
Figure 7 Total number of studies led by authors from each 
income group and risk factors assessed. HIC, high-income 
country; LIC, low-income country; LMIC, low-income and 
middle-income country; UMIC, upper middle-income country.
capacity and softer factors such as the cultural values may 
play a role.
India was disproportionately over-represented in both 
terms of lead researchers and study populations. To 
test whether this was due to its large population size, we 
examined the number of publications per person for 
each country as well as other factors that might influ-
ence publication rate: spending on health, education 
and research and development, as well as physicians per 
capita. These are internationally comparable headline 
metrics routinely used for cross-country comparisons. 
They provide a rough indication of how well developed 
the academic life sciences community is likely to be, 
insofar as countries with very low spending on health, 
education and R&D are unlikely to have, for example, 
an excess of Doctor of Philosophy students working on 
health research. Figure 8 shows that India’s per capita 
publication rate is comparable with its close neighbours 
Pakistan and Bangladesh, but far below Nepal’s publica-
tion rate. We note that this metric is less useful for coun-
tries with single studies and smaller populations. India’s 
national expenditure on health, education and research 
and development is comparable with other countries 
at the same level of economic development, although 
slightly behind Asian peers such as Bangladesh, Vietnam 
and Sri Lanka. Both the Philippines and Indonesia have 
large populations but few publications; however, the 
four countries with the largest number of papers all have 
population sizes >150 million. With over 1.3 billion citi-
zens, India’s dominance seems to be partly explained 
by its large population size. Many academic institutions 
teach and publish in English which may play a role. Other 
contributing factors are harder to measure and compare 
across countries, such as India’s relatively well-established 
research infrastructure and vibrant medical sciences 
community.
Conducting research in LLMICs can be extremely chal-
lenging. Political instability is a long-standing issue, along 
with unpredictable or non-existent research funding, 
weak academic institutions, underdeveloped collabo-
rative relationships between partner organisations and 
language and cultural divides. The paucity of training, 
equipment and qualified personnel exacerbates these 
difficulties.27–29 Dakik argues that North–South collabora-
tion can help to overcome many of these issues, as long as 
the approach is one of equal partnership. Targeting funds 
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Figure 8 Number of studies from each country versus 
papers per person, physicians per 1000 people and 
national expenditure on health, education and research and 
development. GDP, gross domestic product.
to high-performing academics is another way of boosting 
impact and building research capacity in LLMICs.29–31
The main limitation of this study is our focus on poverty 
and behavioural risk factors as a proxy for NCD research. 
Low-income countries may be producing high-impact 
research in other areas that were excluded by our search, 
leading to a precise but inaccurate assessment of research 
output. A broader search would have delivered a more 
robust assessment of global NCD research. Unfortu-
nately, we did not have the resources to handle such a 
large review and so focused on an area that features 
prominently in national and international NCD control 
strategies. Furthermore, research on poverty and NCDs 
has been highlighted as a priority area in the WHO Prior-
itised Research Agenda for NCDs and is central to the 
dominant development framing of the NCD epidemic.32 
Our study is also limited by the assumption that the first 
author is the lead scientist. Strengths of the study include 
comprehensive search terms, the use of multiple data-
bases, a focus on the most important aspect of NCD 
research from a policy perspective and independent dual 
review of papers.
A 2012 bibliometric review by Jones and Geneau25 
showed that the relative proportion of LMIC authors 
leading research on ‘priority interventions for NCDs’ 
(WHO ‘Best Buys’) had increased since 2000. Our study—
focused on NCD risk factor and poverty research—found 
no such trend; however, we did find that tobacco is univer-
sally more studied than other risk factors, corroborating 
their work.
The relative paucity of LLMIC-based NCD research 
units is specifically addressed in the Global Action Plan 
on NCD Prevention and Control 2013–2020.33 Although 
two-thirds of poverty and NCD risk factor research has 
been led by LLMIC-based scientists, they collectively 
represent a minority of LLMICs. We emphasise the 
urgent need to strengthen incentives and capacity in 
these countries to undertake research on bidirectional 
links between NCDs and poverty in order to generate 
evidence to inform policies and programmes to address 
NCDs and poverty alleviation.
cOnclusiOn
LLMICs bear disproportionately high burdens of poverty 
and NCDs, yet four-fifths of these countries have no 
research output on the four main NCD risk factors. This 
deficit is a barrier to the development of effective correc-
tive policies. Building on our quantification of research 
capacity in LLMICs, future work should explore why 
research capacity is so low, and how it can be improved to 
support NCD prevention and control efforts in LLMICs.
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